Race, institutional factors play an important role in pharmacogenomic trial participation
Tuesday, July 28, 2015 - 13:30
in Health & Medicine
The participation rate of patients in pharmacogenomic trials has been the focus of recent study. The research has concluded that there are a number of factors at the patient, physician, institution and community level that serve as incentives or hindrances for clinical trial participation, including beliefs and attitudes, awareness, opportunities and resources.